#Imprimis CEO Mark Baum discusses the new offerings planned for this year via @EyeWireToday at the #HawaiianEyeMtg: bit.ly/2k5rxm5

Setup your account for our new 503B Outsourcing facility today! Get started here: bit.ly/2k8R12j #CataractSurgery #Ophthalmology

#Imprimis CEO Mark Baum talks over-priced drugs, $IMMY's low-cost alternatives, and more: bit.ly/2m6WfZu #compounding #pharma

Dr. Shamik Bafna on Imprimis Pharma MKO melt: What he's learned about this sublingual anesthetic. ow.ly/w2ZG309NkjG

@LessDropsare now available from our #503B Outsourcing Facility, which does not require patient info! Order today: bit.ly/2nCuSHd

Hi @GregoryvalleOD, thanks for tweeting us! Please email us at [email protected] so we can help you further. Sorry for the inconvenience.

Mark Baum shares his thoughts on drug pricing in the pharmaceutical industry Mark Baum ow.ly/Kmlj309VsNj

Imprimis Challenges Mallinckrodt's Acthar benzinga.com/z/9198923 $IMMY $MNK

Imprimis CEO Mark Baum announced today that the #Imprimis team will pursue a lower priced alternative to Mallinckrodt's HP Acthar Gel. x.com/Benzinga/statu…

.Imprimis Pharma announces the publication of a dropless therapy article in Current Pharmaceutical Design #optometry

Dr. Richard Lindstrom discusses the Klarity licensing agreement with #Imprimis via @EyeWireToday - bit.ly/2peRH8q #dryeye

.Imprimis Pharma and Slsurgical sign agreement for launch of Serum Tears autologous serum eye drops for chronic dry eye patients #optometry

You ASKED, we LISTENED: We're proud to announce this exciting agreement w/ Imprimis Pharma & Serum Tears™ ow.ly/Sf1c30bmCAc

Visit us at booth #3038 at #ASCRSASOA2017 to learn more about our Simple Drops preservative-free #glaucoma drops! bit.ly/2psTNkf

Read the new issue of CRST and gain perspective on the tension between big pharma and compounding: hubs.ly/H07vF310 #Ophthalmology

#Imprimis CEO Mark Baum had the honor of giving the 2017 College of Liberal Arts commencement address for The University of Texas at Arlington, his alma mater. x.com/markbaum4/stat…

Our very own CEO Mark Baum has been chosen as a finalist for the Entrepreneur Of The Year 2017 Award in San Diego! bit.ly/2pRU5yA

Imprimis CEO Mark Baum discusses drug pricing and why the government should rethink #compounding in Cataract & Refractive Surgery Today: bit.ly/2rrTm8G

Our very own CEO Mark Baum won the Ernst & Young San Diego Entrepreneur of the Year award in Life Science! Help us in congratulating him!